Medici Therapeutics, Inc.
BiotechnologyOncology Cellular Immunotherapy
Boston, MA
2021
founded
About
Medici Therapeutics, Inc. is a biotechnology company focused on developing advanced cancer treatments within the immunotherapy sector. The company's primary focus is on advancing tumor-infiltrating lymphocyte (TIL) therapies by leveraging novel insights into cancer immunology, particularly how cancer cells evade immune responses.
Company Values
The company's distinct approach involves addressing a newly discovered mechanism of immune evasion where cancer cells sabotage T cells. Medici is developing methods to infuse TILs with healthy mitochondria to enhance their anti-tumor functionality and durability.